Edinburgh Research Explorer

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

Research output: Contribution to journalArticle

Standard

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. / Snowdon, Victoria K.; Lachlan, Neil J.; Hoy, Anna M.; Hadoke, Patrick W. F.; Semple, Scott I.; Patel, Dilip; Mungall, Will; Kendall, Timothy J.; Thomson, Adrian; Lennen, Ross J.; Jansen, Maurits A.; Moran, Carmel M.; Pellicoro, Antonella; Ramachandran, Prakash; Shaw, Isaac; Aucott, Rebecca L.; Severin, Thomas; Saini, Rajnish; Pak, Judy; Yates, Denise; Dongre, Neelesh; Duffield, Jeremy S.; Webb, David J.; Iredale, John P.; Hayes, Peter C.; Fallowfield, Jonathan A.; Taal, Maarten W. (Editor).

In: PLOS Medicine, Vol. 14, No. 2, e1002248, 28.02.2017.

Research output: Contribution to journalArticle

Harvard

Snowdon, VK, Lachlan, NJ, Hoy, AM, Hadoke, PWF, Semple, SI, Patel, D, Mungall, W, Kendall, TJ, Thomson, A, Lennen, RJ, Jansen, MA, Moran, CM, Pellicoro, A, Ramachandran, P, Shaw, I, Aucott, RL, Severin, T, Saini, R, Pak, J, Yates, D, Dongre, N, Duffield, JS, Webb, DJ, Iredale, JP, Hayes, PC, Fallowfield, JA & Taal, MW (ed.) 2017, 'Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial', PLOS Medicine, vol. 14, no. 2, e1002248. https://doi.org/10.1371/journal.pmed.1002248

APA

Snowdon, V. K., Lachlan, N. J., Hoy, A. M., Hadoke, P. W. F., Semple, S. I., Patel, D., ... Taal, M. W. (Ed.) (2017). Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. PLOS Medicine, 14(2), [e1002248]. https://doi.org/10.1371/journal.pmed.1002248

Vancouver

Snowdon VK, Lachlan NJ, Hoy AM, Hadoke PWF, Semple SI, Patel D et al. Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. PLOS Medicine. 2017 Feb 28;14(2). e1002248. https://doi.org/10.1371/journal.pmed.1002248

Author

Snowdon, Victoria K. ; Lachlan, Neil J. ; Hoy, Anna M. ; Hadoke, Patrick W. F. ; Semple, Scott I. ; Patel, Dilip ; Mungall, Will ; Kendall, Timothy J. ; Thomson, Adrian ; Lennen, Ross J. ; Jansen, Maurits A. ; Moran, Carmel M. ; Pellicoro, Antonella ; Ramachandran, Prakash ; Shaw, Isaac ; Aucott, Rebecca L. ; Severin, Thomas ; Saini, Rajnish ; Pak, Judy ; Yates, Denise ; Dongre, Neelesh ; Duffield, Jeremy S. ; Webb, David J. ; Iredale, John P. ; Hayes, Peter C. ; Fallowfield, Jonathan A. ; Taal, Maarten W. (Editor). / Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. In: PLOS Medicine. 2017 ; Vol. 14, No. 2.